Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 3546 entries
View as:

Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis

Phase: N/A Priority: Normal
NCT ID: NCT01086410 Org: User:
Start: 03/31/10 End: 09/30/10 Due: 09/30/11

Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00536809 Org: User:
Start: 09/26/07 End: 10/31/08 Due: 10/31/09

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT06382311 Org: User:
Start: 04/18/24 End: 01/16/26 Due: 01/16/27

Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis

Phase: N/A Priority: Normal
NCT ID: NCT02794467 Org: User:
Start: 07/31/16 End: 10/31/16 Due: 10/31/17

Perennial Allergic Rhinitis Study In Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00108914 Org: User:
Start: 02/28/05 End: 11/30/05 Due: 11/30/06

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

Phase: N/A Priority: Normal
NCT ID: NCT06104319 Org: User:
Start: 01/22/24 End: 09/23/25 Due: 09/23/26

A Study of GW842166 in Adults With Osteoarthritis Pain

Phase: N/A Priority: Normal
NCT ID: NCT00447486 Org: User:
Start: 04/30/07 End: - Due: -

A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06317311 Org: User:
Start: 05/07/24 End: 08/31/27 Due: 08/31/28

Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04446351 Org: User:
Start: 06/25/20 End: 12/31/25 Due: 12/31/26

Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02191397 Org: User:
Start: 02/10/15 End: 10/25/16 Due: 10/25/17

Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study

Phase: N/A Priority: Normal
NCT ID: NCT02100644 Org: User:
Start: 04/12/14 End: 05/11/15 Due: 05/11/16

Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02972905 Org: User:
Start: 10/31/16 End: 12/31/16 Due: 12/31/17

Safety Escalating Repeat IV, in Stroke Patients

Phase: N/A Priority: Normal
NCT ID: NCT00833989 Org: User:
Start: 07/08/09 End: 01/31/11 Due: 01/31/12

Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01428427 Org: User:
Start: 08/12/09 End: 07/18/11 Due: 07/18/12

A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02683785 Org: User:
Start: 03/17/16 End: 11/29/17 Due: 11/29/18

Investigation Of A New Medication (GW642444) In Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00354874 Org: User:
Start: 01/31/05 End: 06/30/05 Due: 06/30/06

Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04878315 Org: User:
Start: 02/13/22 End: 03/25/22 Due: 03/25/23

Efficacy of Three Experimental Toothpastes to Remove Plaque

Phase: N/A Priority: Normal
NCT ID: NCT02992691 Org: User:
Start: 12/19/16 End: 02/02/17 Due: 02/02/18

A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women

Phase: N/A Priority: Normal
NCT ID: NCT03674177 Org: User:
Start: 10/30/18 End: 09/02/19 Due: 09/02/20

Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT03943095 Org: User:
Start: 05/13/19 End: 08/28/19 Due: 08/28/20

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916

Phase: N/A Priority: Normal
NCT ID: NCT02064387 Org: User:
Start: 07/29/14 End: 08/01/19 Due: 08/01/20

Paxil CR Bioequivalence Study Brazil

Phase: N/A Priority: Normal
NCT ID: NCT01316926 Org: User:
Start: 09/09/09 End: 10/05/09 Due: 10/05/10

A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00501267 Org: User:
Start: 06/30/07 End: 08/31/07 Due: 08/31/08

Prevalence of Severe Asthma in Spanish Hospitals

Phase: N/A Priority: Normal
NCT ID: NCT03137043 Org: User:
Start: 11/22/17 End: 06/02/20 Due: 06/02/21

Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence

Phase: N/A Priority: Normal
NCT ID: NCT01390870 Org: User:
Start: 05/31/09 End: 09/30/10 Due: 09/30/11